 Prednisone appearance inflammatory mediators influx eosinophils basophils cutaneous late-phase response effect systemic glucocorticoids cutaneous early late phase response LPR atopic subjects double-blind cross-over study skin chambers denuded skin blisters challenge allergen chamber min subjects pretreatment mg/day prednisone placebo Skin chamber cell counts inflammatory mediators histamine leukotriene hourly intervals Prednisone pretreatment immediate skin erythema release histamine late secondary erythema rise histamine median histamine values placebo prednisone pretreatment visits ng/ml equal Prednisone production production LPR cumulative median values equal placebo prednisone pretreatment Prednisone cellular traffic inflammatory mediators influx eosinophils placebo-treated patients prednisone equal influx basophils placebo-treated patients time points equal prednisone-treated patients significant alteration neutrophil transit skin chambers prednisone selective blockade eosinophil basophil influx prednisone associated decrease inflammatory mediators blockade clinical expression cutaneous LPR